rs111679484

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000334.4(SCN4A):​c.3720+10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.024 in 1,603,828 control chromosomes in the GnomAD database, including 650 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 66 hom., cov: 31)
Exomes 𝑓: 0.024 ( 584 hom. )

Consequence

SCN4A
NM_000334.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.222

Publications

4 publications found
Variant links:
Genes affected
SCN4A (HGNC:10591): (sodium voltage-gated channel alpha subunit 4) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
SCN4A Gene-Disease associations (from GenCC):
  • hyperkalemic periodic paralysis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Orphanet
  • paramyotonia congenita of Von Eulenburg
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Laboratory for Molecular Medicine
  • SCN4A-related myopathy, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, ClinGen, PanelApp Australia
  • hypokalemic periodic paralysis, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • potassium-aggravated myotonia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 16
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital myopathy
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital myopathy 22A, classic
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • acetazolamide-responsive myotonia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypokalemic periodic paralysis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia fluctuans
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myotonia permanens
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 17-63945350-T-C is Benign according to our data. Variant chr17-63945350-T-C is described in ClinVar as Benign. ClinVar VariationId is 255849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0217 (3304/151946) while in subpopulation NFE AF = 0.0316 (2149/67932). AF 95% confidence interval is 0.0305. There are 66 homozygotes in GnomAd4. There are 1720 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 66 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000334.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
NM_000334.4
MANE Select
c.3720+10A>G
intron
N/ANP_000325.4P35499

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN4A
ENST00000435607.3
TSL:1 MANE Select
c.3720+10A>G
intron
N/AENSP00000396320.1P35499

Frequencies

GnomAD3 genomes
AF:
0.0218
AC:
3303
AN:
151832
Hom.:
66
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00358
Gnomad AMI
AF:
0.00769
Gnomad AMR
AF:
0.00741
Gnomad ASJ
AF:
0.0162
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00250
Gnomad FIN
AF:
0.0747
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0316
Gnomad OTH
AF:
0.0139
GnomAD2 exomes
AF:
0.0225
AC:
5499
AN:
244840
AF XY:
0.0225
show subpopulations
Gnomad AFR exome
AF:
0.00344
Gnomad AMR exome
AF:
0.00416
Gnomad ASJ exome
AF:
0.0170
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0776
Gnomad NFE exome
AF:
0.0299
Gnomad OTH exome
AF:
0.0205
GnomAD4 exome
AF:
0.0243
AC:
35264
AN:
1451882
Hom.:
584
Cov.:
33
AF XY:
0.0240
AC XY:
17316
AN XY:
720424
show subpopulations
African (AFR)
AF:
0.00285
AC:
95
AN:
33328
American (AMR)
AF:
0.00458
AC:
204
AN:
44536
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
431
AN:
25746
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39486
South Asian (SAS)
AF:
0.00216
AC:
185
AN:
85730
European-Finnish (FIN)
AF:
0.0736
AC:
3909
AN:
53102
Middle Eastern (MID)
AF:
0.00244
AC:
14
AN:
5728
European-Non Finnish (NFE)
AF:
0.0265
AC:
29250
AN:
1104306
Other (OTH)
AF:
0.0196
AC:
1176
AN:
59920
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1851
3702
5554
7405
9256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
988
1976
2964
3952
4940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0217
AC:
3304
AN:
151946
Hom.:
66
Cov.:
31
AF XY:
0.0232
AC XY:
1720
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.00357
AC:
148
AN:
41450
American (AMR)
AF:
0.00740
AC:
113
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0162
AC:
56
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.00250
AC:
12
AN:
4794
European-Finnish (FIN)
AF:
0.0747
AC:
790
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0316
AC:
2149
AN:
67932
Other (OTH)
AF:
0.0137
AC:
29
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
171
343
514
686
857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0282
Hom.:
38
Bravo
AF:
0.0149
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
Hyperkalemic periodic paralysis (2)
-
-
2
not provided (2)
-
-
1
Congenital myasthenic syndrome 16 (1)
-
-
1
Hypokalemic periodic paralysis, type 2 (1)
-
-
1
Paramyotonia congenita of Von Eulenburg (1)
-
-
1
Potassium-aggravated myotonia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
13
DANN
Benign
0.80
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111679484; hg19: chr17-62022710; API